ZA200302172B - Allergen-microarray assay. - Google Patents
Allergen-microarray assay. Download PDFInfo
- Publication number
- ZA200302172B ZA200302172B ZA200302172A ZA200302172A ZA200302172B ZA 200302172 B ZA200302172 B ZA 200302172B ZA 200302172 A ZA200302172 A ZA 200302172A ZA 200302172 A ZA200302172 A ZA 200302172A ZA 200302172 B ZA200302172 B ZA 200302172B
- Authority
- ZA
- South Africa
- Prior art keywords
- allergens
- immobilized
- microarray chip
- allergen
- ized
- Prior art date
Links
- 238000002493 microarray Methods 0.000 title claims description 74
- 238000003556 assay Methods 0.000 title description 22
- 239000013566 allergen Substances 0.000 claims description 250
- 238000000034 method Methods 0.000 claims description 83
- 206010020751 Hypersensitivity Diseases 0.000 claims description 53
- 230000007815 allergy Effects 0.000 claims description 50
- 108060003951 Immunoglobulin Proteins 0.000 claims description 46
- 102000018358 immunoglobulin Human genes 0.000 claims description 46
- 210000002966 serum Anatomy 0.000 claims description 41
- 208000026935 allergic disease Diseases 0.000 claims description 31
- 229940072221 immunoglobulins Drugs 0.000 claims description 28
- 238000001514 detection method Methods 0.000 claims description 24
- 239000003153 chemical reaction reagent Substances 0.000 claims description 13
- 239000011521 glass Substances 0.000 claims description 12
- 238000003745 diagnosis Methods 0.000 claims description 11
- 238000000338 in vitro Methods 0.000 claims description 9
- 239000012528 membrane Substances 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 7
- 238000012986 modification Methods 0.000 claims description 6
- 230000004048 modification Effects 0.000 claims description 6
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 4
- 230000009471 action Effects 0.000 claims description 4
- 229910052710 silicon Inorganic materials 0.000 claims description 4
- 239000010703 silicon Substances 0.000 claims description 4
- 239000013568 food allergen Substances 0.000 claims description 3
- 239000002435 venom Substances 0.000 claims description 3
- 210000001048 venom Anatomy 0.000 claims description 3
- 231100000611 venom Toxicity 0.000 claims description 3
- 206010056740 Genital discharge Diseases 0.000 claims description 2
- 230000002285 radioactive effect Effects 0.000 claims description 2
- 229960004784 allergens Drugs 0.000 description 139
- 238000012360 testing method Methods 0.000 description 64
- 239000000523 sample Substances 0.000 description 37
- 239000000284 extract Substances 0.000 description 25
- 230000027455 binding Effects 0.000 description 19
- 238000009739 binding Methods 0.000 description 19
- 108090000623 proteins and genes Proteins 0.000 description 18
- 102000004169 proteins and genes Human genes 0.000 description 18
- 239000000126 substance Substances 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 15
- 108091007433 antigens Proteins 0.000 description 14
- 102000036639 antigens Human genes 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 239000000427 antigen Substances 0.000 description 13
- 208000010668 atopic eczema Diseases 0.000 description 13
- 229940074608 allergen extract Drugs 0.000 description 11
- 230000000172 allergic effect Effects 0.000 description 11
- 108090000765 processed proteins & peptides Proteins 0.000 description 11
- 230000008901 benefit Effects 0.000 description 10
- 239000006180 TBST buffer Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 8
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 238000002965 ELISA Methods 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 238000003018 immunoassay Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 238000000018 DNA microarray Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 210000000987 immune system Anatomy 0.000 description 5
- 239000007790 solid phase Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 231100000640 hair analysis Toxicity 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 241000269837 Artemisia dubia Species 0.000 description 3
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 3
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 230000002009 allergenic effect Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000013537 high throughput screening Methods 0.000 description 3
- 210000004408 hybridoma Anatomy 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- SGNVTRHWJGTNKV-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 11-(2,5-dioxopyrrol-1-yl)undecanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCCCCCCCCCN1C(=O)C=CC1=O SGNVTRHWJGTNKV-UHFFFAOYSA-N 0.000 description 2
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 2
- 241000238876 Acari Species 0.000 description 2
- 206010003645 Atopy Diseases 0.000 description 2
- 241000272201 Columbiformes Species 0.000 description 2
- 241000699800 Cricetinae Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 108010003272 Hyaluronate lyase Proteins 0.000 description 2
- 102000001974 Hyaluronidases Human genes 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 241000746981 Phleum Species 0.000 description 2
- 102000015439 Phospholipases Human genes 0.000 description 2
- 108010064785 Phospholipases Proteins 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 102000011195 Profilin Human genes 0.000 description 2
- 108050001408 Profilin Proteins 0.000 description 2
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 229960002773 hyaluronidase Drugs 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 238000010324 immunological assay Methods 0.000 description 2
- 239000003547 immunosorbent Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- -1 microtiter I ‘plates Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229940079938 nitrocellulose Drugs 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 238000003498 protein array Methods 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000012099 Alexa Fluor family Substances 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000219429 Betula Species 0.000 description 1
- 235000003932 Betula Nutrition 0.000 description 1
- 241000238658 Blattella Species 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 101000693911 Equus caballus Albumin Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010052140 Eye pruritus Diseases 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010061958 Food Intolerance Diseases 0.000 description 1
- 230000010663 Gene Expression Interactions Effects 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 244000084296 Hernandia moerenhoutiana Species 0.000 description 1
- 235000010044 Hernandia moerenhoutiana Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 102000000646 Interleukin-3 Human genes 0.000 description 1
- 108010002386 Interleukin-3 Proteins 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000555688 Malassezia furfur Species 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000595626 Plodia Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010026552 Proteome Proteins 0.000 description 1
- 208000037339 Rare allergic disease Diseases 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040102 Seroma Diseases 0.000 description 1
- 240000006694 Stellaria media Species 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 102000009843 Thyroglobulin Human genes 0.000 description 1
- 108010034949 Thyroglobulin Proteins 0.000 description 1
- 241000251221 Triakidae Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000002715 bioenergetic effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229940000425 combination drug Drugs 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 239000012502 diagnostic product Substances 0.000 description 1
- 230000001083 documented effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000010501 heavy metal poisoning Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003455 independent Effects 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940076264 interleukin-3 Drugs 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004001 molecular interaction Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000004223 overdiagnosis Methods 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000036515 potency Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940070376 protein Drugs 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000010181 skin prick test Methods 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229960003339 sodium phosphate Drugs 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940043517 specific immunoglobulins Drugs 0.000 description 1
- 239000005315 stained glass Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 229960002175 thyroglobulin Drugs 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- PZJJKWKADRNWSW-UHFFFAOYSA-N trimethoxysilicon Chemical group CO[Si](OC)OC PZJJKWKADRNWSW-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 208000034280 venom allergy Diseases 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00890296A EP1195606A1 (en) | 2000-10-03 | 2000-10-03 | Allergen-microarray assay |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200302172B true ZA200302172B (en) | 2004-02-16 |
Family
ID=8175969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200302172A ZA200302172B (en) | 2000-10-03 | 2003-03-18 | Allergen-microarray assay. |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20050101031A1 (es) |
| EP (2) | EP1195606A1 (es) |
| CN (1) | CN1325919C (es) |
| AT (1) | ATE286597T1 (es) |
| AU (2) | AU2002212306B2 (es) |
| BR (1) | BRPI0114343B8 (es) |
| CA (1) | CA2424661C (es) |
| CZ (1) | CZ305183B6 (es) |
| DE (1) | DE60108256T3 (es) |
| DK (1) | DK1322960T4 (es) |
| EE (1) | EE05465B1 (es) |
| ES (1) | ES2234909T5 (es) |
| HK (1) | HK1066276A1 (es) |
| HU (1) | HU228066B1 (es) |
| MX (1) | MXPA03002750A (es) |
| PT (1) | PT1322960E (es) |
| RU (1) | RU2276790C2 (es) |
| SI (1) | SI1322960T2 (es) |
| SK (1) | SK286541B6 (es) |
| WO (1) | WO2002029415A1 (es) |
| ZA (1) | ZA200302172B (es) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030109067A1 (en) | 2001-12-06 | 2003-06-12 | Immunetech, Inc. | Homogeneous immunoassays for multiple allergens |
| EP1338895A1 (en) * | 2002-02-21 | 2003-08-27 | Co-Wealth Medical Science & Biotechnology, Inc. | High density allergen microarray |
| DE50310049D1 (de) * | 2002-12-23 | 2008-08-07 | Febit Biotech Gmbh | Einbau von hapten-gruppen bei der herstellung von trägern für die analytbestimmung |
| US20090111702A1 (en) * | 2004-04-06 | 2009-04-30 | Mount Sinai School Of Medicine Office Of Industrial Liason | Methods of determining allergen response using microarray immunoassay techniques |
| EP1922332A2 (en) * | 2005-09-09 | 2008-05-21 | The University Of Chicago | Methods and compositions for diagnosis and immunotherapy of pollen allergy |
| US7761149B2 (en) * | 2007-03-28 | 2010-07-20 | The Institute Of Natural Health Technologies, Inc. | Electrical stimulus allergy treatment method |
| US20100210033A1 (en) * | 2007-10-07 | 2010-08-19 | Jordan Scott | Portable device for detecting food allergens |
| DK2225266T3 (en) * | 2007-11-30 | 2017-08-07 | Phadia Ab | Hitherto unknown allergens |
| KR101490377B1 (ko) * | 2008-05-08 | 2015-02-05 | 삼성전자주식회사 | 알레르기 질환 진단용 표면탄성파 센서 및 상기 센서를이용한 알레르기 질환 진단방법 |
| US20110275095A1 (en) * | 2009-01-29 | 2011-11-10 | Siemens Healthcare Diagnostics Inc. | Microarrays for Allergen-Specific IgE |
| US20110243993A1 (en) * | 2010-03-29 | 2011-10-06 | Broo Kerstin S | Method for diagnosing and creating immunogenic tolerance in contact allergy and other epithelial immunotoxicological ailments |
| CN102478571A (zh) * | 2010-11-23 | 2012-05-30 | 南京神州英诺华医疗科技有限公司 | 一种新的过敏原体外诊断实验方法及其装置 |
| WO2012129246A2 (en) * | 2011-03-20 | 2012-09-27 | The Regents Of The University Of Colorado, A Body Corporate | Method for predicting severity of allergic reaction |
| GB2490652A (en) * | 2011-04-18 | 2012-11-14 | Microtest Matrices Ltd | Methods of quantifying antibodies, especially IgE antibodies in a sample |
| RU2629310C2 (ru) | 2011-09-14 | 2017-08-28 | Пхадиа Аб | Калибровочный реагент и способ |
| FR2987129B1 (fr) * | 2012-02-21 | 2014-03-14 | Commissariat Energie Atomique | Capteurs de nez ou de langue electronique |
| GB201223256D0 (en) * | 2012-12-21 | 2013-02-06 | Microtest Matrices Ltd | Immunoassay |
| CN103454412B (zh) * | 2013-09-16 | 2015-02-18 | 南京博敏达生物科技有限公司 | 一种用于过敏原特异性抗体检测的液相芯片及其制备方法 |
| CN103675271B (zh) * | 2013-12-23 | 2016-01-06 | 北京新华联协和药业有限责任公司 | 过敏性疾病变应原胶体金诊断试纸条及其制备方法 |
| AU2015294723B2 (en) | 2014-07-21 | 2021-05-06 | Phadia Ab | Novel allergen |
| WO2016077808A1 (en) | 2014-11-14 | 2016-05-19 | Biomerica, Inc. | Compositions, devices, and methods of ibs sensitivity testing |
| CA2968681C (en) | 2014-12-09 | 2021-03-30 | Nader SOLIMAN | Treatment of allergies and autoimmune diseases |
| MX2018002947A (es) * | 2015-09-09 | 2018-06-08 | Biomerica Inc | Composiciones, dispositivos, y métodos de pruebas de sensibilidad a la osteoartritis. |
| ES2862533T3 (es) * | 2016-03-30 | 2021-10-07 | Macroarray Diagnostics Gmbh | Matriz de antígenos |
| WO2017218546A1 (en) * | 2016-06-13 | 2017-12-21 | Biomerica, Inc. | Compositions, devices, and methods of gastroesophageal reflux disease sensitivity testing |
| EP3497447A4 (en) * | 2016-07-08 | 2020-01-22 | Biomerica Inc. | COMPOSITIONS, DEVICES, AND METHODS FOR ASSESSING SENSITIVITY TO LOW PRESSURE |
| CN108802399A (zh) * | 2017-04-28 | 2018-11-13 | 中国医学科学院基础医学研究所 | 一种检测过敏原的新型蛋白质芯片 |
| BR102017027544A2 (pt) * | 2017-12-20 | 2021-11-09 | Fundação Universidade Estadual Do Ceará - Funece | Kit e processo para detecção de imunoglobulinas e e imunoglobulinas g1 |
| US11408895B1 (en) | 2018-04-09 | 2022-08-09 | Hob Biotech Group Corp., Ltd. | Allergen characterization, potent allergen product formulation, comprehensive allergen reagent, and allergy assay |
| JPWO2021015123A1 (es) * | 2019-07-25 | 2021-01-28 | ||
| WO2023287325A1 (ru) * | 2021-07-13 | 2023-01-19 | Дмитрий Евгеньевич ГЛУХОВ | Способ мультиспектрального зондирования для диагностики биологических объектов |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US444879A (en) * | 1891-01-20 | Insulator | ||
| US3720760A (en) * | 1968-09-06 | 1973-03-13 | Pharmacia Ab | Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples |
| US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
| NL8102178A (nl) * | 1981-05-02 | 1982-12-01 | Stichting Centraal Lab | Werkwijze voor het aantonen van tegen bepaalde antigenen gerichte antistoffen, alsmede inrichting en reagentia voor het uitvoeren van deze werkwijze. |
| US4629706A (en) * | 1982-02-01 | 1986-12-16 | Miles Laboratories, Inc. | Method for determining allergic sensitivity |
| US4845027B1 (en) * | 1982-10-13 | 1994-05-10 | Biowhittaker Inc | Fluorometric assay of allergic reactions |
| US4844966A (en) * | 1982-10-13 | 1989-07-04 | Minnesota Mining And Manufacturing Company | Assaying total IgE levels with fluorogenic enzyme labeled antibody |
| US4564600A (en) * | 1982-10-26 | 1986-01-14 | Majid Ali | Allergens and antibodies from allergen extracts and pooled serum |
| US4849337A (en) * | 1983-01-31 | 1989-07-18 | Minnesota Mining And Manufacturing Company | Assaying allergen specific IgE levels with fluorogenic enzyme labeled antibody |
| US4949338A (en) * | 1987-04-06 | 1990-08-14 | Racal Data Communications Inc. | Arbitration in multiprocessor communication node |
| US5807755A (en) * | 1987-08-06 | 1998-09-15 | Multilyte Limited | Determination of ambient concentrations of several analytes |
| US5075077A (en) * | 1988-08-02 | 1991-12-24 | Abbott Laboratories | Test card for performing assays |
| US6379895B1 (en) * | 1989-06-07 | 2002-04-30 | Affymetrix, Inc. | Photolithographic and other means for manufacturing arrays |
| US5512283A (en) * | 1990-07-06 | 1996-04-30 | Allergene, Inc. | Methods for the selective suppression of an immune response to dust mite der Pi |
| EP0556745A1 (en) * | 1992-02-21 | 1993-08-25 | Abbott Laboratories | Method for detection of anti-wheat-protein antibodies |
| US5480972A (en) * | 1992-10-30 | 1996-01-02 | The University Of Melbourne | Allergenic proteins from Johnson grass pollen |
| ES2108566T3 (es) * | 1993-12-10 | 1997-12-16 | Genentech Inc | Procedimientos para diagnosticar alergias y para seleccionar agentes terapeuticos antialergicos. |
| US5945294A (en) * | 1996-11-26 | 1999-08-31 | Heska Corporation | Method to detect IgE |
| WO1999025826A1 (en) * | 1997-11-13 | 1999-05-27 | University Of Manitoba | Method and kit for determining severe inflammatory reactions to mosquito bites |
| US6406921B1 (en) * | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
| EP1785726A1 (en) * | 1999-02-17 | 2007-05-16 | Carbozyme NT Ltd | Combinatioral complex carbohydrate libraries and methods for the manufacture and uses thereof |
| US20030166518A1 (en) * | 2000-01-13 | 2003-09-04 | Beardslee Thomas A. | Method for allergen characterization |
| US6531283B1 (en) * | 2000-06-20 | 2003-03-11 | Molecular Staging, Inc. | Protein expression profiling |
| CA2314398A1 (en) * | 2000-08-10 | 2002-02-10 | Edward Shipwash | Microarrays and microsystems for amino acid analysis and protein sequencing |
| US20020187464A1 (en) * | 2000-09-22 | 2002-12-12 | Klempner Mark S. | Microarray-based method for rapid identification of cells, microorganisms, or protein mixtures |
| US6528325B1 (en) * | 2000-10-13 | 2003-03-04 | Dexall Biomedical Labs, Inc. | Method for the visual detection of specific antibodies in human serum by the use of lateral flow assays |
-
2000
- 2000-10-03 EP EP00890296A patent/EP1195606A1/en not_active Withdrawn
-
2001
- 2001-10-03 SI SI200130325T patent/SI1322960T2/sl unknown
- 2001-10-03 ES ES01980473T patent/ES2234909T5/es not_active Expired - Lifetime
- 2001-10-03 US US10/398,266 patent/US20050101031A1/en not_active Abandoned
- 2001-10-03 EE EEP200300128A patent/EE05465B1/xx unknown
- 2001-10-03 DK DK01980473.1T patent/DK1322960T4/da active
- 2001-10-03 CZ CZ2003-1219A patent/CZ305183B6/cs not_active IP Right Cessation
- 2001-10-03 PT PT01980473T patent/PT1322960E/pt unknown
- 2001-10-03 EP EP01980473A patent/EP1322960B2/en not_active Expired - Lifetime
- 2001-10-03 AT AT01980473T patent/ATE286597T1/de active
- 2001-10-03 BR BRPI0114343A patent/BRPI0114343B8/pt not_active IP Right Cessation
- 2001-10-03 CA CA2424661A patent/CA2424661C/en not_active Expired - Lifetime
- 2001-10-03 CN CNB018167969A patent/CN1325919C/zh not_active Expired - Lifetime
- 2001-10-03 AU AU2002212306A patent/AU2002212306B2/en not_active Expired
- 2001-10-03 DE DE60108256.7T patent/DE60108256T3/de not_active Expired - Lifetime
- 2001-10-03 WO PCT/EP2001/011429 patent/WO2002029415A1/en active IP Right Grant
- 2001-10-03 AU AU1230602A patent/AU1230602A/xx active Pending
- 2001-10-03 HU HU0303663A patent/HU228066B1/hu unknown
- 2001-10-03 SK SK537-2003A patent/SK286541B6/sk not_active IP Right Cessation
- 2001-10-03 MX MXPA03002750A patent/MXPA03002750A/es active IP Right Grant
- 2001-10-03 RU RU2003112699/15A patent/RU2276790C2/ru active IP Right Revival
-
2003
- 2003-03-18 ZA ZA200302172A patent/ZA200302172B/en unknown
-
2004
- 2004-11-16 HK HK04109024A patent/HK1066276A1/xx not_active IP Right Cessation
-
2007
- 2007-10-30 US US11/929,498 patent/US20080139406A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2424661C (en) | Allergen-microarray assay | |
| AU2002212306A1 (en) | Allergen-microarray assay | |
| US11740232B2 (en) | Antigen array | |
| JP5792626B2 (ja) | 補体固定抗体の検出のための方法および組成物 | |
| US5270167A (en) | Methods of identification employing antibody profiles | |
| US20110065594A1 (en) | Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual | |
| Mari et al. | Microarrayed allergen molecules for the diagnosis of allergic diseases | |
| US9410965B2 (en) | Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual | |
| JP2002286716A (ja) | 複数項目同時分析可能なイムノクロマトグラフ法及びイムノクロマトグラフ用ストリップ | |
| EP2047269B1 (en) | Measurement of complement activation products on antigen microarrays | |
| JP4627607B2 (ja) | 複数項目及び総含有量の同時分析可能なイムノクロマトグラフ法及びイムノクロマトグラフ用ストリップ | |
| US8178344B2 (en) | System and method for antigen structure-independent detection of antigens captured on antibody arrays | |
| CA1231047A (en) | Diagnostic test for rheumatological diseases | |
| EP2756312B1 (en) | Calibration reagent and method | |
| AU2009247267A1 (en) | Method for quantification of antigen-specific canine or human IgE | |
| EP1635691A2 (en) | Methods and compositions for use in diagnosing and characterizing diseases involving abnormal apoptosis | |
| Akar-Ghibril et al. | In vitro methods to assess allergy | |
| Redegeld et al. | Antibody Detection | |
| WO2008147345A2 (en) | System and method for antigen structure-independent detection of antigens captured on antibody arrays |